139 related articles for article (PubMed ID: 6840836)
1. Influence of physicochemical parameters on adsorption of Actinomyces viscosus to hydroxyapatite surfaces.
Wheeler TT; Clark WB; Lane MD; Grow TE
Infect Immun; 1983 Mar; 39(3):1095-101. PubMed ID: 6840836
[TBL] [Abstract][Full Text] [Related]
2. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo.
Wheeler TT; Clark WB; Birdsell DC
Infect Immun; 1979 Sep; 25(3):1066-74. PubMed ID: 500185
[TBL] [Abstract][Full Text] [Related]
3. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
[TBL] [Abstract][Full Text] [Related]
4. Role of bacterial interactions in the colonization of oral surfaces of Actinomyces viscosus.
Kuramitsu HK; Paul A
Infect Immun; 1980 Jul; 29(1):83-90. PubMed ID: 6772577
[TBL] [Abstract][Full Text] [Related]
5. Differences in the adsorptive behavior of human strains of Actinomyces viscosus and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
Qureshi JV; Gibbons RJ
Infect Immun; 1981 Jan; 31(1):261-6. PubMed ID: 7216448
[TBL] [Abstract][Full Text] [Related]
6. Specific inhibition of adsorption of Actinomyces viscosus T14V to saliva-treated hydroxyapatite by antibody against type 1 fimbriae.
Clark WB; Wheeler TT; Cisar JO
Infect Immun; 1984 Feb; 43(2):497-501. PubMed ID: 6141143
[TBL] [Abstract][Full Text] [Related]
7. Comparative estimates of bacterial affinities and adsorption sites on hydroxyapatite surfaces.
Clark WB; Bammann LL; Gibbons RJ
Infect Immun; 1978 Mar; 19(3):846-53. PubMed ID: 640732
[TBL] [Abstract][Full Text] [Related]
8. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.
Cisar JO; Vatter AE; McIntire FC
Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593
[TBL] [Abstract][Full Text] [Related]
9. Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite.
Wheeler TT; Clark WB
Infect Immun; 1980 May; 28(2):577-84. PubMed ID: 7399676
[TBL] [Abstract][Full Text] [Related]
10. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
Powell JT; Fischlschweiger W; Birdsell DC
Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
[TBL] [Abstract][Full Text] [Related]
11. Relative hydrophobicities of Actinomyces viscosus and Actinomyces naeslundii strains and their adsorption to saliva-treated hydroxyapatite.
Clark WB; Lane MD; Beem JE; Bragg SL; Wheeler TT
Infect Immun; 1985 Mar; 47(3):730-6. PubMed ID: 3972451
[TBL] [Abstract][Full Text] [Related]
12. Actinomyces adsorption mediated by type-1 fimbriae.
Clark WB; Wheeler TT; Lane MD; Cisar JO
J Dent Res; 1986 Sep; 65(9):1166-8. PubMed ID: 2874164
[TBL] [Abstract][Full Text] [Related]
13. Influence of growth medium on adsorption of Streptococcus mutans, Actinomyces viscosus, and Actinomyces naeslundii to saliva-treated hydroxyapatite surfaces.
Peros WJ; Gibbons RJ
Infect Immun; 1981 Apr; 32(1):111-7. PubMed ID: 7216480
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of adherence of Actinomyces naeslundii (Actinomyces viscosus) T14V-J1 to saliva-treated hydroxyapatite by a monoclonal antibody to type 1 fimbriae.
Nesbitt WE; Beem JE; Leung KP; Stroup S; Swift R; McArthur WP; Clark WB
Oral Microbiol Immunol; 1996 Feb; 11(1):51-8. PubMed ID: 8604255
[TBL] [Abstract][Full Text] [Related]
15. Human salivary acidic proline-rich proteins and statherin promote the attachment of Actinomyces viscosus LY7 to apatitic surfaces.
Gibbons RJ; Hay DI
Infect Immun; 1988 Feb; 56(2):439-45. PubMed ID: 2892794
[TBL] [Abstract][Full Text] [Related]
16. Actinomyces viscosus colonization of mouse teeth.
Crawford PC; Clark WB
J Dent Res; 1986 Feb; 65(2):105-8. PubMed ID: 3455963
[TBL] [Abstract][Full Text] [Related]
17. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
[TBL] [Abstract][Full Text] [Related]
18. Chemical characterization of extracellular polysaccharides produced by Actinomyces viscosus T14V and T14Av.
Imai S; Kuramitsu H
Infect Immun; 1983 Mar; 39(3):1059-66. PubMed ID: 6840834
[TBL] [Abstract][Full Text] [Related]
19. Fimbria-specific antibodies in serum and saliva of mice immunized with Actinomyces viscosus T14V fimbriae.
Crawford PC; Clark WB
Infect Immun; 1986 Nov; 54(2):507-15. PubMed ID: 2876962
[TBL] [Abstract][Full Text] [Related]
20. A study of in vitro attachment of Streptococcus sanguis and Actinomyces viscosus to saliva-treated titanium.
Wolinsky LE; de Camargo PM; Erard JC; Newman MG
Int J Oral Maxillofac Implants; 1989; 4(1):27-31. PubMed ID: 2599579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
